HEPA logo

Hepion Pharmaceuticals (HEPA) Total Liabilities

Annual Total Liabilities

$10.81 M
+$425.10 K+4.09%

31 December 2023

HEPA Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$4.12 M
+$1.67 M+68.35%

30 September 2024

HEPA Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HEPA Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.1%-53.4%
3 y3 years+33.1%-54.0%
5 y5 years+74.0%-15.0%

HEPA Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+33.1%-74.6%+68.3%
5 y5 yearsat high+116.5%-74.6%+68.3%
alltimeall time-8.3%+4659.5%-74.6%+1041.8%

Hepion Pharmaceuticals Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$4.12 M(+68.4%)
June 2024
-
$2.45 M(-71.1%)
Mar 2024
-
$8.47 M(-21.7%)
Dec 2023
$10.81 M(+4.1%)
$10.81 M(+22.3%)
Sept 2023
-
$8.84 M(-12.7%)
June 2023
-
$10.13 M(-17.9%)
Mar 2023
-
$12.34 M(+18.8%)
Dec 2022
$10.39 M(-1.6%)
$10.39 M(-0.5%)
Sept 2022
-
$10.44 M(-35.7%)
June 2022
-
$16.25 M(+76.2%)
Mar 2022
-
$9.22 M(-12.7%)
Dec 2021
$10.56 M(+29.9%)
$10.56 M(+17.8%)
Sept 2021
-
$8.96 M(-0.8%)
June 2021
-
$9.03 M(+46.1%)
Mar 2021
-
$6.18 M(-23.9%)
Dec 2020
$8.12 M(+62.7%)
$8.12 M(+8.5%)
Sept 2020
-
$7.49 M(+29.3%)
June 2020
-
$5.79 M(+28.6%)
Mar 2020
-
$4.50 M(-9.9%)
Dec 2019
$4.99 M(-19.6%)
$4.99 M(+3.1%)
Sept 2019
-
$4.85 M(-8.7%)
June 2019
-
$5.31 M(-26.8%)
Mar 2019
-
$7.26 M(+16.8%)
DateAnnualQuarterly
Dec 2018
$6.21 M(-17.7%)
$6.21 M(-36.1%)
Sept 2018
-
$9.73 M(+11.5%)
June 2018
-
$8.73 M(+37.5%)
Mar 2018
-
$6.34 M(-30.5%)
Dec 2017
$7.55 M(-19.1%)
-
Sept 2017
-
$9.13 M(-2.1%)
June 2017
$9.33 M(-20.9%)
$9.33 M(-23.2%)
Mar 2017
-
$12.15 M(+19.2%)
Dec 2016
-
$10.19 M(-13.7%)
Sept 2016
-
$11.81 M(+0.2%)
June 2016
$11.79 M(+508.3%)
$11.79 M(+116.1%)
Mar 2016
-
$5.45 M(-3.7%)
Dec 2015
-
$5.66 M(+34.3%)
Sept 2015
-
$4.21 M(+117.5%)
June 2015
$1.94 M(-60.7%)
$1.94 M(+20.0%)
Mar 2015
-
$1.62 M(+347.6%)
Dec 2014
-
$361.00 K(-22.3%)
Sept 2014
-
$464.70 K(-90.6%)
June 2014
$4.93 M(+2071.7%)
$4.93 M(-50.6%)
Mar 2014
-
$9.99 M(+1902.4%)
Dec 2013
-
$498.70 K(+25.1%)
Sept 2013
-
$398.60 K
June 2013
$227.20 K
-

FAQ

  • What is Hepion Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for Hepion Pharmaceuticals?
  • What is Hepion Pharmaceuticals annual total liabilities year-on-year change?
  • What is Hepion Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Hepion Pharmaceuticals?
  • What is Hepion Pharmaceuticals quarterly total liabilities year-on-year change?

What is Hepion Pharmaceuticals annual total liabilities?

The current annual total liabilities of HEPA is $10.81 M

What is the all time high annual total liabilities for Hepion Pharmaceuticals?

Hepion Pharmaceuticals all-time high annual total liabilities is $11.79 M

What is Hepion Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, HEPA annual total liabilities has changed by +$425.10 K (+4.09%)

What is Hepion Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of HEPA is $4.12 M

What is the all time high quarterly total liabilities for Hepion Pharmaceuticals?

Hepion Pharmaceuticals all-time high quarterly total liabilities is $16.25 M

What is Hepion Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, HEPA quarterly total liabilities has changed by -$4.72 M (-53.40%)